Skip to content

A CLINICAL TRIAL ON SIDDHA FORMULATION THETRAN VITHAI KUDINEER CHOORANAM FOR MADHUMEGAM

TO EVALUATE THE EFFICACY OF SIDDHA FORMULATION THETRAN VITHAI KUDINEER CHOORANAM IN THE MANAGEMENT OF MADHUMEGAM (PILOT STUDY)

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019362
Enrollment
20
Registered
2019-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: NIL: NIL Intervention2: THETRAN VITHAI KUDINEER CHOORANAM: DRUG - THETRAN VITHAI KUDINEER CHOORANAM DOSE- 2 GM FREQUENCY - THRICE A DAY VEHICLE - BUTTER MILK DURATION - 3 MONTHS (90 DAY

Sponsors

AyothidossPandithar Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: FASTING BLOOD SUGAR > 130 mg/dl POSTPRANDIAL BLOOD SUGAR >200 mg/dl HBA1C > 6.5 DIABETES WITH HYPERTENSION

Exclusion criteria

Exclusion criteria: IDDM (Insulin Dependent Diabetes Mellitus) HbA1C > 9 Cardiac diseases, Pulmonary diseases, Renal diseases, Thyroid dysfunctions, Gestational diabetes, Other endocrine abnormalities Patient who are not willing to give blood sample, Patients under allopathy medication, Patients developed any complicatiions of Diabetes Mellitus.

Design outcomes

Primary

MeasureTime frame
To Evaluvate the Therapeutic efficacy of siddha formulation THETRAN VITHAI KUDINEER CHOORANAM in the treatment of MADHUMEGAM (TYPE II DIABETES MELLITUS)Timepoint: 1 YEAR

Secondary

MeasureTime frame
SECONDARY OBJECTIVE: To prepare the trial medicine as per Standard Operative procedure To study the siddha cofactors related to the disease such as age,sex,etc. To find out the side effects of the drug, if any. Timepoint: 3 MONTHS

Countries

India

Contacts

Public ContactDR VISWESWARAN

NATIONAL INSTITUTE OF SIDDHA

svisu11@gmail.com9962542755

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026